Since its foundation, WuXi AppTec has helped strengthen global life sciences collaboration by connecting innovators, enabling knowledge exchange, and fostering dialogue across the drug development ecosystem. By working with partners across discovery, development, and manufacturing, the company contributes to a more integrated and collaborative environment that supports the advancement of new medicines for global patients.

This is essential for the life sciences industry. Stakeholders, including biotech companies, pharmaceutical organizations, and academic institutions, often operate across different geographies, disciplines, and stages of development. This complexity can create barriers to communication, limit the industry’s ability to share perspectives, and slow the pace of innovation.

WuXi AppTec addresses these challenges by leveraging its deep industry insight, long-standing relationships, and global engagement initiatives. Through structured platforms, cross-sector collaboration, and active community involvement, the company helps connect stakeholders, align perspectives, and enable more effective collaboration across the global life sciences ecosystem.

WuXi AppTec Brings Together Global Stakeholders Through Flagship Forums and Regional Events

WuXi AppTec strengthens connections across the global life sciences ecosystem by hosting high-impact events within leading biotech clusters, including San Francisco, London, and other key innovation hubs across the world. These platforms bring together scientists, investors, and industry leaders to exchange viewpoints, build partnerships, and explore the future of drug development.

For more than 14 years, WuXi AppTec has hosted the annual WuXi Global Forum alongside the J.P. Morgan Healthcare Conference in San Francisco, convening thousands of global leaders each year. The forum reflects the industry’s shared commitment to advancing innovation for patients, with discussions led by leading experts and key opinion leaders. In 2026, the forum carried additional significance, featuring participation from 2025 Nobel Prize Laureate Dr. Fred Ramsdell and highlighting a new era of collaboration at a critical inflection point for the industry.

The WuXi Global Forum has consistently received strong, positive feedback from participants across the industry. Attendees have described the event as “inspiring,” noting the opportunity to engage with thought leaders and peers who are shaping the future of healthcare. These reflections highlight the forum’s role not only as a gathering, but as a platform that fosters meaningful dialogue and reinforces a shared commitment to improving patient outcomes.

In addition to its flagship forum, WuXi AppTec hosts events such as “WuXi Innovation Day” and “WuXi Night” alongside major conferences across Europe, including BIO-Europe, Nordic Life Science Days, and the Jefferies Global Healthcare Conference in London. These gatherings bring together hundreds of industry participants in key biotech hubs, creating an environment for open discussion on topics such as translating innovation into therapies, advancing new modalities, and strengthening global collaboration.

These events have also been widely recognized by industry leaders and key opinion leaders as valuable platforms for connection and exchange. Participants consistently emphasize the importance of dialogue, trust, and long-term partnership in advancing innovation, and view these gatherings as opportunities to build relationships that extend beyond individual meetings. Through these continued engagements, WuXi AppTec helps reinforce a more connected and collaborative global life sciences ecosystem.

WuXi AppTec Strengthens Ecosystem Communication Through Workshops, Conferences, and Networking Initiatives

WuXi AppTec fosters communication across the life sciences ecosystem by creating opportunities for stakeholders to exchange perspectives, build relationships, and align on scientific and development challenges. Through workshops, conference engagement, and sponsored initiatives, the company helps bring together researchers, investors, and industry professionals to enable more effective collaboration.

At its global sites, WuXi AppTec plays an active role in local ecosystems by hosting workshops, training sessions, and community events. In Europe, for example, the Crelux team regularly brings together scientists, investors, and innovators to discuss practical topics such as building strong partnerships and preparing for next-stage development. As one team member noted, “Sometimes we are scientists, sometimes we are facilitators.” These interactions help local companies strengthen their capabilities while building trust within the regional innovation community.

WuXi AppTec also extends these efforts to major industry conferences, where it organizes dedicated workshops to engage with the broader scientific community. In a recent case, WuXi AppTec hosted two sessions at the 10th AMR Conference in Basel, covering its infectious disease platform and case studies in antimicrobial drug discovery. These sessions provide a platform for attendees to explore real-world approaches, discuss challenges, and connect with experts working at the forefront of the field.

In addition, WuXi AppTec supports industry dialogue by sponsoring targeted networking events that bring together specific communities. Examples include the Women Networking Breakfast during DCAT Week 2026, as well as the Women in TPD Networking Event, designed to foster connection, mentorship, and leadership development within the targeted protein degradation field. By creating inclusive spaces for scientists and professionals to share experiences and build relationships, these initiatives contribute to a more collaborative and diverse innovation ecosystem.

WuXi AppTec Advances Industry Learning by Sharing Practical Experience and Global Perspectives

WuXi AppTec contributes to the advancement of the life sciences industry by sharing practical experience and expert perspectives that support more informed decision-making across drug development. By making its accumulated experience accessible and amplifying insights from global leaders, the company helps enable broader learning and more efficient progress across the ecosystem.

Drawing on years of experience supporting frontier modalities, WuXi AppTec has accumulated deep practical understanding across areas such as DMPK (Drug Metabolism and Pharmacokinetics) and emerging therapeutic platforms. Rather than keeping these insights internal, the team partnered with Wiley to publish Drug Metabolism and Pharmacokinetics: Frontiers, Strategies, and Applications. The book was designed to provide clear guidance on new modalities, common challenges, and practical strategies, helping scientists across the industry navigate increasingly complex drug development landscapes.

The publication was widely recognized by the scientific community. Within weeks of release, printed copies were distributed globally and quickly became a trusted reference at major conferences. As noted by the team, “If others can learn from our experience and avoid common mistakes, that helps everyone move faster.” This response reflects the industry’s demand for practical, experience-based guidance and highlights the value of making such perspectives broadly accessible.

In addition to publishing, WuXi AppTec shares insights from global key opinion leaders through its newsletters, covering topics that are highly relevant to the industry. In 2025, these included areas such as rare diseases, healthy aging, and central nervous system (CNS) disorders. Featuring perspectives from leaders across biotech, pharma, academia, and investment, these publications provide a platform for diverse viewpoints on scientific, clinical, and ecosystem challenges.

These newsletters have been well received globally, reaching a broad audience across the life sciences community, with total readership exceeding 70,000. This level of engagement reflects the relevance of the topics covered and the value of bringing together expert perspectives to support ongoing dialogue and collaboration across the industry.

Closing: WuXi AppTec Strengthens Global Collaboration to Advance the Future of Drug Development

As the industry becomes increasingly complex, the ability to connect ideas, align stakeholders, and enable meaningful exchange will continue to shape the pace of innovation. WuXi AppTec’s approach, combining deep industry understanding with global platforms and active engagement, contributes to a more integrated ecosystem where collaboration can happen more effectively.

WuXi AppTec remains committed to building connections that support scientific progress and help translate innovation into therapies for patients worldwide.

Key Takeaways

•    WuXi AppTec helps reduce fragmentation and enables more effective collaboration across drug development by linking biotech companies, pharmaceutical organizations, academic institutions, and investors,

•    WuXi AppTec brings together global leaders in key biotech hubs to exchange perspectives, build partnerships, and advance innovation through initiatives such as the WuXi Global Forum, WuXi Innovation Day, and WuXi Night,

•    WuXi AppTec facilitates direct engagement among scientists, investors, and industry professionals, helping align goals and accelerate progress by hosting workshops, conference sessions, and targeted networking events,

•    WuXi AppTec helps scientists navigate complex challenges and avoid common pitfalls by sharing practical experience, including through publications such as Drug Metabolism and Pharmacokinetics: Frontiers, Strategies, and Applications, which provide actionable guidance on emerging modalities.

•    WuXi AppTec brings together insights from KOLs across pharma, biotech, academia, and investment through newsletters covering topics such as rare diseases, healthy aging, CNS disorders, and beyond.